Annual EBITDA
-$151.35M$123.35M-440.55%
Summary
- Current Value
- As of today, IMNM annual EBITDA is -$151.35M, down -440.55% on
- Historical Performance
- IMNM annual EBITDA is down -519.06% over the past 3 years, and down -1456.66% over the past 5 years
- All-Time High Comparison
- IMNM annual EBITDA is currently -2007.11% below its historical high of -$7.18M set on
- 3-Year Low Comparison
- IMNM annual EBITDA is at its 3-year low
- Sector Comparison
- IMNM annual EBITDA is higher than 11.21% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$151.35M | -440.6% | -519.1% | -1456.7% | -2007.1% | |
| Quarterly EBITDA | -$59.41M | -37.4% | -605.5% | -2149.3% | -2215.1% | |
| TTM EBITDA | -$204.08M | +34.0% | -459.6% | -2554.1% | -7853.1% | |
| Price | $22.41 | +127.3% | +460.3% | +63.2% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $9.04M | -35.5% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | -$5.00 | +7.2% | -133.3% | -403.2% | -570.0% | |
| Annual EBIT | -$153.46M | -434.2% | -508.9% | -1384.4% | -1891.9% | |
| Annual Net Income | -$292.96M | -174.3% | -1085.6% | -2705.1% | -3634.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$28.00M | -440.6% | |
| 5Y | -$17.04M | N/A | -788.0% |
| All | -$7.18M | -2007.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$151.35M | at low | |
| 5Y | -$151.35M | at low | |
| All | -$151.35M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$151.35M | -440.6% | |
| -$28.00M | +22.8% | |
| -$36.27M | -48.3% | |
| -$24.45M | -43.4% |
| Year | Value | Change |
|---|---|---|
| -$17.04M | -75.3% | |
| -$9.72M | -35.4% | |
| -$7.18M | - |
FAQ
What is the current annual EBITDA of IMNM?
As of today, IMNM annual EBITDA is -$151.35M
What is 1-year change in IMNM annual EBITDA?
IMNM annual EBITDA is down -440.55% year-over-year
What is 3-year change in IMNM annual EBITDA?
IMNM annual EBITDA is down -519.06% over the past 3 years
How far is IMNM annual EBITDA from its all-time high?
IMNM annual EBITDA is currently -2007.11% below its historical high of -$7.18M set on December 31, 2018
How does IMNM annual EBITDA rank versus sector peers?
IMNM annual EBITDA is higher than 11.21% of companies in Healthcare sector
When is IMNM next annual earnings release?
The next annual earnings release for IMNM is on
Quarterly EBITDA
-$59.41M$13.65M-29.82%
Summary
- Current Value
- As of today, IMNM quarterly EBITDA is -$59.41M, down -29.82% on
- Historical Performance
- IMNM quarterly EBITDA is down -37.37% year-over-year, and down -605.52% over the past 3 years
- All-Time High Comparison
- IMNM quarterly EBITDA is currently -2283.83% below its historical high of -$2.49M set on
- 3-Year Low Comparison
- IMNM quarterly EBITDA is +55.01% above its 3-year low of -$132.04M reached on
- Sector Comparison
- IMNM quarterly EBITDA is higher than 5.97% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$59.41M | -29.8% | -37.4% | -605.5% | -2149.3% | |
| Annual EBITDA | -$151.35M | – | -440.6% | -519.1% | -1456.7% | |
| TTM EBITDA | -$204.08M | -8.6% | +34.0% | -459.6% | -2554.1% | |
| Price | $22.41 | +35.9% | +127.3% | +460.3% | +63.2% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | -100.0% | -100.0% | 0.0% | 0.0% | |
| Quarterly EPS | -$0.65 | -30.9% | +16.5% | +7.2% | +17.8% | |
| Quarterly EBIT | -$60.14M | -29.4% | -37.3% | -604.7% | -2034.1% | |
| Quarterly Net Income | -$57.46M | -32.4% | -22.0% | -573.4% | -585.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$43.91M | -35.3% | |
| 3Y | -$4.32M | -1274.2% | |
| 5Y | -$3.72M | -1496.5% | |
| All | -$2.49M | -2283.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$59.41M | at low | |
| 3Y | -$132.04M | +55.0% | |
| 5Y | -$132.04M | +55.0% | |
| All | -$132.04M | +55.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of IMNM?
As of today, IMNM quarterly EBITDA is -$59.41M
What is IMNM quarterly EBITDA most recent change?
IMNM quarterly EBITDA was down -29.82% on September 30, 2025
What is 1-year change in IMNM quarterly EBITDA?
IMNM quarterly EBITDA is down -37.37% year-over-year
How far is IMNM quarterly EBITDA from its all-time high?
IMNM quarterly EBITDA is currently -2283.83% below its historical high of -$2.49M set on March 31, 2020
How does IMNM quarterly EBITDA rank versus sector peers?
IMNM quarterly EBITDA is higher than 5.97% of companies in Healthcare sector
When is IMNM next earnings release?
The next earnings release for IMNM is on
TTM EBITDA
-$204.08M$16.16M-8.60%
Summary
- Current Value
- As of today, IMNM TTM EBITDA is -$204.08M, down -8.60% on
- Historical Performance
- IMNM TTM EBITDA is up +33.96% year-over-year, and down -459.59% over the past 3 years
- All-Time High Comparison
- IMNM TTM EBITDA is currently -7853.08% below its historical high of -$2.57M set on
- 3-Year Low Comparison
- IMNM TTM EBITDA is +33.96% above its 3-year low of -$309.01M reached on
- Sector Comparison
- IMNM TTM EBITDA is higher than 7.05% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$204.08M | -8.6% | +34.0% | -459.6% | -2554.1% | |
| Annual EBITDA | -$151.35M | – | -440.6% | -519.1% | -1456.7% | |
| Quarterly EBITDA | -$59.41M | -29.8% | -37.4% | -605.5% | -2149.3% | |
| Price | $22.41 | +35.9% | +127.3% | +460.3% | +63.2% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $9.68M | -23.1% | -4.4% | +100.0% | +100.0% | |
| TTM EPS | -$2.96 | +4.2% | +63.6% | +3.0% | +15.2% | |
| TTM EBIT | -$206.85M | -8.6% | +33.4% | -459.7% | -2426.3% | |
| TTM Net Income | -$222.74M | -4.9% | +27.1% | -502.6% | -1518.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$181.49M | -12.4% | |
| 3Y | -$21.93M | -830.5% | |
| 5Y | -$11.51M | N/A | -1673.7% |
| All | -$2.57M | -7853.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$269.62M | N/A | +24.3% |
| 3Y | -$309.01M | +34.0% | |
| 5Y | -$309.01M | +34.0% | |
| All | -$309.01M | +34.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of IMNM?
As of today, IMNM TTM EBITDA is -$204.08M
What is IMNM TTM EBITDA most recent change?
IMNM TTM EBITDA was down -8.60% on September 30, 2025
What is 1-year change in IMNM TTM EBITDA?
IMNM TTM EBITDA is up +33.96% year-over-year
How far is IMNM TTM EBITDA from its all-time high?
IMNM TTM EBITDA is currently -7853.08% below its historical high of -$2.57M set on September 30, 2019
How does IMNM TTM EBITDA rank versus sector peers?
IMNM TTM EBITDA is higher than 7.05% of companies in Healthcare sector
When is IMNM next earnings release?
The next earnings release for IMNM is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- IMNM Official Website immunome.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1472012/000119312525269603/0001193125-25-269603-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1472012/000155837025003302/0001558370-25-003302-index.htm
- IMNM Profile on Yahoo Finance finance.yahoo.com/quote/IMNM
- IMNM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/imnm